Ligand Stimulation of a Ret Chimeric Receptor Carrying the Activating Mutation Responsible for the Multiple Endocrine Neoplasia Type 2B

This publication has 25 references indexed in Scilit:

• RET oncogene
  Current Opinion in Genetics & Development, 1996
• Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations
  Molecular and Cellular Biology, 1995
• Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
  Nature, 1995
• Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
  Science, 1995
• Inherited cancers associated with the RET proto-oncogene
  Current Opinion in Genetics & Development, 1994
• Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.
  Proceedings of the National Academy of Sciences, 1994
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
  Nature, 1994
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
  Human Molecular Genetics, 1993
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
  Nature, 1993
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
  Proceedings of the National Academy of Sciences, 1976